Common variable immunodeficiency in two kindreds with heterogeneous phenotypes caused by novel heterozygous NFKB1 mutations

NFKB1 haploinsufficiengcy was first described in 2015 in three families with common variable immunodeficiency (CVID), presenting heterogeneously with symptoms of increased infectious susceptibility, skin lesions, malignant lymphoproliferation and autoimmunity. The described mutations all led to a rapid degradation of the mutant protein, resulting in a p50 haploinsufficient state. Since then, more than 50 other mutations have been reported, located throughout different domains of NFKB1 with the majority situated in the N-terminal Rel homology domain (RHD). The clinical spectrum has also expanded with possible disease manifestations in almost any organ system. In silico prediction tools are often used to estimate the pathogenicity of NFKB1 variants but to prove causality between disease and genetic findings, further downstream functional validation is required. In this report, we studied 2 families with CVID and two novel variants in NFKB1 (c.1638-2A>G and c.787G>C). Both mutations affected mRNA and/or protein expression of NFKB1 and resulted in excessive NLRP3 inflammasome activation in patient macrophages and upregulated interferon stimulated gene expression. Protein-protein interaction analysis demonstrated a loss of interaction with NFKB1 interaction partners for the p.V263L mutation. In conclusion, we proved pathogenicity of two novel variants in NFKB1 in two families with CVID characterized by variable and incomplete penetrance.

[1]  C. Wells,et al.  Defining the Role of Nuclear Factor (NF)-κB p105 Subunit in Human Macrophage by Transcriptomic Analysis of NFKB1 Knockout THP1 Cells , 2021, Frontiers in Immunology.

[2]  Rigbe G Weldatsadik,et al.  Combined proximity labeling and affinity purification−mass spectrometry workflow for mapping and visualizing protein interaction networks , 2020, Nature Protocols.

[3]  I. Aksentijevich,et al.  Mendelian diseases of dysregulated canonical NF‐κB signaling: From immunodeficiency to inflammation , 2020, Journal of leukocyte biology.

[4]  William J. Astle,et al.  Characterization of the clinical and immunological phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations. , 2020, The Journal of allergy and clinical immunology.

[5]  J. Kere,et al.  Novel TMEM173 Mutation and the Role of Disease Modifying Alleles , 2019, Front. Immunol..

[6]  He Huang,et al.  ff19SB: Amino-acid specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. , 2019, Journal of chemical theory and computation.

[7]  M. Fliegauf,et al.  Nuclear factor κB mutations in human subjects: The devil is in the details. , 2018, The Journal of allergy and clinical immunology.

[8]  Crina Samarghitean,et al.  Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans , 2018, The Journal of allergy and clinical immunology.

[9]  M. Karin,et al.  NF-κB, inflammation, immunity and cancer: coming of age , 2018, Nature Reviews Immunology.

[10]  J. Kere,et al.  Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes , 2017, The Journal of allergy and clinical immunology.

[11]  Shao-Cong Sun,et al.  NF-κB signaling in inflammation , 2017, Signal Transduction and Targeted Therapy.

[12]  V. Lougaris,et al.  NFKB1 regulates human NK cell maturation and effector functions. , 2017, Clinical immunology.

[13]  Samuel J Kuzminski,et al.  The Devil Is in the Details. , 2017, Journal of the American College of Radiology : JACR.

[14]  A. Schäffer,et al.  Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency. , 2015, American journal of human genetics.

[15]  M. Feldmann,et al.  RelB/p50 regulates TNF production in LPS-stimulated dendritic cells and macrophages. , 2013, Cytokine.

[16]  L. Pfeffer The role of nuclear factor κB in the interferon response. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[17]  P. Ratcliffe,et al.  FIH‐Dependent Asparaginyl Hydroxylation of Ankyrin Repeat Domain‐Containing Proteins , 2009, Annals of the New York Academy of Sciences.

[18]  S. Ghosh,et al.  The NF-kappaB family of transcription factors and its regulation. , 2009, Cold Spring Harbor perspectives in biology.

[19]  L. Fitzpatrick,et al.  NF-κB1 p105 Regulates T Cell Homeostasis and Prevents Chronic Inflammation1 , 2009, The Journal of Immunology.

[20]  J. Marshall Coming of age. , 2008, Surgical infections.

[21]  P. Ratcliffe,et al.  Posttranslational hydroxylation of ankyrin repeats in IκB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH) , 2006, Proceedings of the National Academy of Sciences.

[22]  S. Ley,et al.  Functions of NF-?B1 and NF-?B2 in immune cell biology , 2004 .

[23]  G. Bren,et al.  Transcription of the RelB gene is regulated by NF-κB , 2001, Oncogene.

[24]  L. Miele,et al.  Human Notch-1 Inhibits NF-κB Activity in the Nucleus Through a Direct Interaction Involving a Novel Domain1 , 2001, The Journal of Immunology.

[25]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..